Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Evaluation of Candida peritonitis with underlying peritoneal fibrosis and efficacy of micafungin in murine models of intra-abdominal candidiasis.

Ashizawa N, Miyazaki T, Abe S, Takazono T, Saijo T, Obata Y, Shimamura S, Yamamoto K, Imamura Y, Koji T, Nishino T, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

Sci Rep. 2019 Jun 27;9(1):9331. doi: 10.1038/s41598-019-45776-x.

2.

The efficacy and safety of sitafloxacin and garenoxacin for the treatment of pneumonia in elderly patients: A randomized, multicenter, open-label trial.

Miyazaki T, Nakamura S, Hashiguchi K, Kobayashi T, Fukushima K, Fukuda Y, Kondo A, Inoue Y, Koga H, Sasaki E, Nagayoshi Y, Higashiyama Y, Yoshida M, Takazono T, Saijo T, Morinaga Y, Yamamoto K, Imamura Y, Mikushi S, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

J Infect Chemother. 2019 May 18. pii: S1341-321X(19)30128-X. doi: 10.1016/j.jiac.2019.04.019. [Epub ahead of print]

3.

Efficacy and safety of cefditoren pivoxil for exacerbations of chronic obstructive pulmonary disease: A prospective multicenter interventional study.

Miyazaki T, Fukushima K, Hashiguchi K, Inoue Y, Mihara T, Sawai T, Suyama N, Kobayashi T, Kondo A, Fukuda Y, Harada Y, Sasaki E, Kaku N, Ide S, Takazono T, Saijo T, Kosai K, Morinaga Y, Nakamura S, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

J Infect Chemother. 2019 Sep;25(9):702-707. doi: 10.1016/j.jiac.2019.03.018. Epub 2019 Apr 11.

4.

Selection of oral antifungals for initial maintenance therapy in chronic pulmonary aspergillosis: A longitudinal analysis.

Tashiro M, Takazono T, Saijo T, Yamamoto K, Imamura Y, Miyazaki T, Kakeya H, Ando T, Ogawa K, Kishi K, Tokimatsu I, Hayashi Y, Fujiuchi S, Yanagihara K, Miyazaki Y, Ichihara K, Mukae H, Kohno S, Izumikawa K.

Clin Infect Dis. 2019 Apr 9. pii: ciz287. doi: 10.1093/cid/ciz287. [Epub ahead of print]

PMID:
30959519
5.

Evaluation of Aspergillus-Specific Lateral-Flow Device Test Using Serum and Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis.

Takazono T, Ito Y, Tashiro M, Nishimura K, Saijo T, Yamamoto K, Imamura Y, Miyazaki T, Yanagihara K, Mukae H, Izumikawa K.

J Clin Microbiol. 2019 Apr 26;57(5). pii: e00095-19. doi: 10.1128/JCM.00095-19. Print 2019 May.

PMID:
30842231
6.

Autophagy-Inducing Factor Atg1 Is Required for Virulence in the Pathogenic Fungus Candida glabrata.

Shimamura S, Miyazaki T, Tashiro M, Takazono T, Saijo T, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

Front Microbiol. 2019 Jan 25;10:27. doi: 10.3389/fmicb.2019.00027. eCollection 2019.

7.

Clinical features and cause analysis of false positive results of Aspergillus galactomannan assay in pulmonary cryptococcosis patients.

Takazono T, Saijo T, Ashizawa N, Oshima K, Nishimura K, Tashiro M, Yamamoto K, Imamura Y, Miyazaki T, Yanagihara K, Mukae H, Izumikawa K, Sheppard DC.

Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):735-741. doi: 10.1007/s10096-019-03469-3. Epub 2019 Jan 25.

PMID:
30684164
8.

Vacuolar proton-translocating ATPase is required for antifungal resistance and virulence of Candida glabrata.

Minematsu A, Miyazaki T, Shimamura S, Nishikawa H, Nakayama H, Takazono T, Saijo T, Yamamoto K, Imamura Y, Yanagihara K, Kohno S, Mukae H, Izumikawa K.

PLoS One. 2019 Jan 23;14(1):e0210883. doi: 10.1371/journal.pone.0210883. eCollection 2019.

9.

A case of bilateral emphysematous pyelonephritis caused by Candida albicans.

Ideguchi S, Yamamoto K, Ikeda A, Hashimoto K, Takazono T, Saijo T, Imamura Y, Miyazaki T, Mukae H.

J Infect Chemother. 2019 Apr;25(4):302-306. doi: 10.1016/j.jiac.2018.10.011. Epub 2018 Nov 15. Review.

PMID:
30448360
10.

Recent Advances in Diagnosing Chronic Pulmonary Aspergillosis.

Takazono T, Izumikawa K.

Front Microbiol. 2018 Aug 17;9:1810. doi: 10.3389/fmicb.2018.01810. eCollection 2018. Review.

11.

Clinical and Microbiological Characteristics of Candida guilliermondii and Candida fermentati.

Hirayama T, Miyazaki T, Yamagishi Y, Mikamo H, Ueda T, Nakajima K, Takesue Y, Higashi Y, Yamamoto Y, Kimura M, Araoka H, Taniguchi S, Fukuda Y, Matsuo Y, Furutani A, Yamashita K, Takazono T, Saijo T, Shimamura S, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e02528-17. doi: 10.1128/AAC.02528-17. Print 2018 Jun.

12.

Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia.

Tashiro M, Fushimi K, Kawano K, Takazono T, Saijo T, Yamamoto K, Kurihara S, Imamura Y, Miyazaki T, Yanagihara K, Mukae H, Izumikawa K.

BMC Pulm Med. 2017 Dec 29;17(1):219. doi: 10.1186/s12890-017-0566-4.

13.

Comparison of Efficacy of Antimicrobial Agents Among Hospitalized Patients With Mycoplasma pneumoniae Pneumonia in Japan During Large Epidemics of Macrolide-Resistant M. pneumoniae Infections: A Nationwide Observational Study.

Tashiro M, Fushimi K, Kawano K, Takazono T, Saijo T, Yamamoto K, Kurihara S, Imamura Y, Miyazaki T, Yanagihara K, Mukae H, Izumikawa K.

Clin Infect Dis. 2017 Nov 13;65(11):1837-1842. doi: 10.1093/cid/cix695.

PMID:
29020161
14.

Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species.

Nagayoshi Y, Miyazaki T, Shimamura S, Nakayama H, Minematsu A, Yamauchi S, Takazono T, Nakamura S, Yanagihara K, Kohno S, Mukae H, Izumikawa K.

PLoS One. 2017 Jul 11;12(7):e0180990. doi: 10.1371/journal.pone.0180990. eCollection 2017.

15.

Examination of cryptococcal glucuronoxylomannan antigen in bronchoalveolar lavage fluid for diagnosing pulmonary cryptococcosis in HIV-negative patients.

Oshima K, Takazono T, Saijo T, Tashiro M, Kurihara S, Yamamoto K, Imamura Y, Miyazaki T, Tsukamoto M, Yanagihara K, Mukae H, Kohno S, Izumikawa K.

Med Mycol. 2018 Jan 1;56(1):88-94. doi: 10.1093/mmy/myx010.

PMID:
28419364
16.

A case series of histoplasmosis patients with elevated serum soluble interleukin-2 receptor levels.

Hirayama T, Takazono T, Iwata K, Senju H, Shimazaki T, Tashiro M, Saijo T, Tanaka T, Nakamura S, Imamura Y, Kojiro M, Miyazaki T, Tsukamoto M, Furumoto A, Morimoto K, Muraosa Y, Matsubara Y, Yanagihara K, Mukae H, Kamei K, Kohno S, Izumikawa K.

J Infect Chemother. 2017 Sep;23(9):642-647. doi: 10.1016/j.jiac.2017.03.006. Epub 2017 Apr 8.

PMID:
28395939
17.

In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.

Nishikawa H, Fukuda Y, Mitsuyama J, Tashiro M, Tanaka A, Takazono T, Saijo T, Yamamoto K, Nakamura S, Imamura Y, Miyazaki T, Kakeya H, Yamamoto Y, Yanagihara K, Mukae H, Kohno S, Izumikawa K.

J Antimicrob Chemother. 2017 Jun 1;72(6):1709-1713. doi: 10.1093/jac/dkx020.

18.

Aspergillus in chronic lung disease: Modeling what goes on in the airways.

Takazono T, Sheppard DC.

Med Mycol. 2017 Jan 1;55(1):39-47. Epub 2016 Nov 12. Review.

PMID:
27838644
19.

Recurrent Streptococcus agalactiae Toxic Shock Syndrome Triggered by a Tumor Necrosis Factor-α Inhibitor.

Yoshida M, Takazono T, Tashiro M, Saijo T, Morinaga Y, Yamamoto K, Nakamura S, Imamura Y, Miyazaki T, Sawai T, Nishino T, Izumikawa K, Yanagihara K, Mukae H, Kohno S.

Intern Med. 2016;55(21):3211-3214. Epub 2016 Nov 1.

20.

Relapsed Pulmonary Cryptococcosis during Tumor Necrosis Factor α Inhibitor Treatment.

Takazono T, Sawai T, Tashiro M, Saijo T, Yamamoto K, Imamura Y, Miyazaki T, Suyama N, Izumikawa K, Kakeya H, Yanagihara K, Mukae H, Kohno S.

Intern Med. 2016;55(19):2877-2880. Epub 2016 Oct 1.

21.

An Autopsy Case of Lepidic Pulmonary Metastasis from Cholangiocarcinoma.

Nagayoshi Y, Yamamoto K, Hashimoto S, Hisatomi K, Doi S, Nagashima S, Kurohama H, Ito M, Takazono T, Nakamura S, Miyazaki T, Kohno S.

Intern Med. 2016;55(19):2849-2853. Epub 2016 Oct 1.

22.

Successful Treatment of Aspergillus Empyema Using Open Window Thoracostomy Salvage Treatment and the Local Administration of an Antifungal Agent.

Ashizawa N, Nakamura S, Ide S, Tashiro M, Takazono T, Imamura Y, Miyazaki T, Izumikawa K, Yamamoto Y, Yanagihara K, Miyazaki Y, Kohno S.

Intern Med. 2016;55(15):2093-9. doi: 10.2169/internalmedicine.55.6250. Epub 2016 Aug 1.

23.

Roles of vacuolar H+-ATPase in the oxidative stress response of Candida glabrata.

Nishikawa H, Miyazaki T, Nakayama H, Minematsu A, Yamauchi S, Yamashita K, Takazono T, Shimamura S, Nakamura S, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

FEMS Yeast Res. 2016 Aug;16(5). pii: fow054. doi: 10.1093/femsyr/fow054. Epub 2016 Jul 1.

PMID:
27370212
24.

[SERODIAGNOSIS OF THE MYCOBACTERIUM AVIUM COMPLEX BY USING IgA ANTIBODIES FOR THE GLYCOPEPTIDOLIPID CORE ANTIGEN].

Higashi Y, Nakamura S, Tomono H, Ide S, Takazono T, Miyazaki T, Izumikawa K, Yanagihara K, Yamamoto Y, Kohno S.

Kekkaku. 2016 Feb;91(2):27-32. Japanese.

PMID:
27263221
25.

Pulmonary Nocardiosis Caused by Nocardia concava with a Literature Review.

Hirayama T, Takazono T, Horai Y, Tashiro M, Saijo T, Kosai K, Morinaga Y, Kurihara S, Nakamura S, Imamura Y, Miyazaki T, Tsukamoto M, Izumikawa K, Yanagihara K, Kawakami A, Kohno S.

Intern Med. 2016;55(9):1213-7. doi: 10.2169/internalmedicine.55.6228. Epub 2016 May 1.

26.

The world first two cases of severe fever with thrombocytopenia syndrome: An epidemiological study in Nagasaki, Japan.

Kurihara S, Satoh A, Yu F, Hayasaka D, Shimojima M, Tashiro M, Saijo T, Takazono T, Imamura Y, Miyazaki T, Tsukamoto M, Yanagihara K, Mukae H, Saijo M, Morita K, Kohno S, Izumikawa K.

J Infect Chemother. 2016 Jul;22(7):461-5. doi: 10.1016/j.jiac.2016.04.001. Epub 2016 Apr 30.

PMID:
27142979
27.

A mortality prediction rule for non-elderly patients with community-acquired pneumonia.

Tashiro M, Fushimi K, Takazono T, Kurihara S, Miyazaki T, Tsukamoto M, Yanagihara K, Mukae H, Tashiro T, Kohno S, Izumikawa K.

BMC Pulm Med. 2016 Mar 8;16:39. doi: 10.1186/s12890-016-0199-z.

28.

The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria.

Takeda K, Imamura Y, Takazono T, Yoshida M, Ide S, Hirano K, Tashiro M, Saijo T, Kosai K, Morinaga Y, Nakamura S, Kurihara S, Tsukamoto M, Miyazaki T, Tashiro T, Kohno S, Yanagihara K, Izumikawa K.

Med Mycol. 2016 Feb;54(2):120-7. doi: 10.1093/mmy/myv093. Epub 2015 Nov 3.

PMID:
26531100
29.

Clinical characteristics and risk factors of enterococcal infections in Nagasaki, Japan: a retrospective study.

Kajihara T, Nakamura S, Iwanaga N, Oshima K, Takazono T, Miyazaki T, Izumikawa K, Yanagihara K, Kohno N, Kohno S.

BMC Infect Dis. 2015 Oct 16;15:426. doi: 10.1186/s12879-015-1175-6.

30.

Macrolides Promote CCL2-Mediated Macrophage Recruitment and Clearance of Nasopharyngeal Pneumococcal Colonization in Mice.

Iwanaga N, Nakamura S, Oshima K, Kajihara T, Takazono T, Miyazaki T, Izumikawa K, Yanagihara K, Sugawara A, Sunazuka T, Omura S, Kohno S.

J Infect Dis. 2015 Oct 1;212(7):1150-9. doi: 10.1093/infdis/jiv157. Epub 2015 Mar 12.

PMID:
25767216
31.

[Two cases of emphysematous urinary tract infections successfully treated with conservative management].

Higashi Y, Nakamura S, Oshima K, Iwanaga N, Hirayama T, Kajihara T, Takazono T, Miyazaki T, Izumikawa K, Yanagihara K, Tashiro T, Kohno S.

Kansenshogaku Zasshi. 2014 Nov;88(6):861-5. Japanese.

PMID:
25764809
32.

A fatal case of acute myocardial infarction following the improvement of influenza A(H1N1)pdm2009-related acute myocarditis.

Iwanaga N, Nakamura S, Fukuda Y, Takazono T, Imamura Y, Izumikawa K, Yanagihara K, Soda H, Tashiro T, Kohno S.

Intern Med. 2014;53(18):2153-7. Epub 2014 Sep 15.

33.

Contribution of the Slt2-regulated transcription factors to echinocandin tolerance in Candida glabrata.

Nagayoshi Y, Miyazaki T, Minematsu A, Yamauchi S, Takazono T, Nakamura S, Imamura Y, Izumikawa K, Kakeya H, Yanagihara K, Kohno S.

FEMS Yeast Res. 2014 Nov;14(7):1128-31. doi: 10.1111/1567-1364.12204. Epub 2014 Sep 19.

34.

Three cases of concurrent infection with Mycobacterium tuberculosis and Cryptococcus neoformans.

Kakeya H, Izumikawa K, Yamada K, Obata Y, Nishino T, Takazono T, Kosai K, Kurihara S, Nakamura S, Imamura Y, Miyazaki T, Tsukamoto M, Yanagihara K, Tashiro T, Kohno S.

Intern Med. 2014;53(15):1685-92. Epub 2014 Aug 1.

35.

Importance of functional assessment in the management of community-acquired and healthcare-associated pneumonia.

Kosai K, Izumikawa K, Imamura Y, Tanaka H, Tsukamoto M, Kurihara S, Takazono T, Morinaga Y, Nakamura S, Miyazaki T, Yanagihara K, Tashiro T, Kohno S.

Intern Med. 2014;53(15):1613-20. Epub 2014 Aug 1.

36.

Concurrent subcutaneous candidal abscesses and pulmonary cryptococcosis in a patient with diabetes mellitus and a history of corticosteroid therapy.

Kakeya H, Izumikawa K, Yamada K, Narita Y, Nishino T, Obata Y, Takazono T, Kurihara S, Kosai K, Morinaga Y, Nakamura S, Imamura Y, Miyazaki T, Tsukamoto M, Yanagihara K, Takenaka M, Tashiro T, Kohno S.

Intern Med. 2014;53(12):1385-90. Epub 2014 Jun 15.

37.

A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.

Takazono T, Nakamura S, Imamura Y, Yoshioka S, Miyazaki T, Izumikawa K, Sawai T, Matsuo N, Yanagihara K, Suyama N, Kohno S.

J Infect Chemother. 2014 Aug;20(8):484-8. doi: 10.1016/j.jiac.2014.04.010. Epub 2014 May 21.

PMID:
24855912
38.

Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-α inhibitor: a case report.

Takazono T, Nakamura S, Imamura Y, Miyazaki T, Izumikawa K, Kakeya H, Yanagihara K, Kohno S.

BMC Infect Dis. 2014 Feb 28;14:114. doi: 10.1186/1471-2334-14-114.

39.

Pathogenesis and clinical features of chronic pulmonary aspergillosis - is it possible to distinguish CNPA and CCPA clinically?

Izumikawa K, Tashiro T, Tashiro M, Takazono T, Kosai K, Morinaga Y, Kurihara S, Nakamura S, Imamura Y, Miyazaki T, Tsukamoto M, Kakeya H, Hayashi T, Yanagihara K, Nagayasu T, Kohno S.

J Infect Chemother. 2014 Mar;20(3):208-12. doi: 10.1016/j.jiac.2013.10.016. Epub 2013 Dec 11.

PMID:
24477329
40.

Efficacy of aerosolized liposomal amphotericin B against murine invasive pulmonary mucormycosis.

Mihara T, Kakeya H, Izumikawa K, Obata Y, Nishino T, Takazono T, Kosai K, Morinaga Y, Kurihara S, Nakamura S, Imamura Y, Miyazaki T, Tsukamoto M, Yamamoto Y, Yanagihara K, Tashiro T, Kohno S.

J Infect Chemother. 2014 Feb;20(2):104-8. doi: 10.1016/j.jiac.2013.09.002. Epub 2013 Dec 11.

PMID:
24462443
41.

Clinical features, risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia: a review of the Japanese literature.

Izumikawa K, Izumikawa K, Takazono T, Kosai K, Morinaga Y, Nakamura S, Kurihara S, Imamura Y, Miyazaki T, Tsukamoto M, Yanagihara K, Hara K, Kohno S.

J Infect Chemother. 2014 Mar;20(3):181-5. doi: 10.1016/j.jiac.2013.09.009. Epub 2013 Dec 11. Review.

PMID:
24462437
42.

Cavitary pulmonary metastases and aspergillosis: an autopsy case.

Takazono T, Izumikawa K, Suyama N, Kohno S.

Intern Med. 2013;52(15):1751-2. Epub 2012 Mar 1. No abstract available.

43.

Possible pulmonary cryptococcosis in a patient with Crohn's disease during anti-tumor necrosis factor-alpha treatment: a case report and literature review.

Takazono T, Izumikawa K, Yoshioka S, Matsuo N, Yamakawa M, Suyama N, Kohno S.

Jpn J Infect Dis. 2012;65(5):461-4. No abstract available.

44.

Multilocus sequence typing of Cryptococcus neoformans in non-HIV associated cryptococcosis in Nagasaki, Japan.

Mihara T, Izumikawa K, Kakeya H, Ngamskulrungroj P, Umeyama T, Takazono T, Tashiro M, Nakamura S, Imamura Y, Miyazaki T, Ohno H, Yamamoto Y, Yanagihara K, Miyzaki Y, Kohno S.

Med Mycol. 2013 Apr;51(3):252-60. doi: 10.3109/13693786.2012.708883. Epub 2012 Aug 17.

PMID:
22901045
45.

A 44-year-old Japanese female with recurrent pleuritis.

Takazono T, Yoshioka S, Matsuo N, Mizokami A, Migita K, Suyama N, Kohno S.

Respiration. 2012;84(4):334-6. Epub 2012 Jul 19. No abstract available.

46.

Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus.

Tashiro M, Izumikawa K, Hirano K, Ide S, Mihara T, Hosogaya N, Takazono T, Morinaga Y, Nakamura S, Kurihara S, Imamura Y, Miyazaki T, Nishino T, Tsukamoto M, Kakeya H, Yamamoto Y, Yanagihara K, Yasuoka A, Tashiro T, Kohno S.

Antimicrob Agents Chemother. 2012 Sep;56(9):4870-5. doi: 10.1128/AAC.00514-12. Epub 2012 Jul 2.

47.

Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis.

Izumikawa K, Yamamoto Y, Mihara T, Takazono T, Morinaga Y, Kurihara S, Nakamura S, Imamura Y, Miyazaki T, Nishino T, Tsukamoto M, Kakeya H, Yanagihara K, Mine M, Yasuoka A, Tashiro T, Kohno S.

Med Mycol. 2012 Nov;50(8):811-7. doi: 10.3109/13693786.2012.682228. Epub 2012 May 9.

PMID:
22568603
48.

A case of bronchial aspergillosis caused by Aspergillus udagawae and its mycological features.

Gyotoku H, Izumikawa K, Ikeda H, Takazono T, Morinaga Y, Nakamura S, Imamura Y, Nishino T, Miyazaki T, Kakeya H, Yamamoto Y, Yanagihara K, Yasuoka A, Yaguchi T, Ohno H, Miyzaki Y, Kamei K, Kanda T, Kohno S.

Med Mycol. 2012 Aug;50(6):631-6. doi: 10.3109/13693786.2011.639036. Epub 2011 Dec 13.

PMID:
22149972
49.

Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.

Tashiro M, Izumikawa K, Minematsu A, Hirano K, Iwanaga N, Ide S, Mihara T, Hosogaya N, Takazono T, Morinaga Y, Nakamura S, Kurihara S, Imamura Y, Miyazaki T, Nishino T, Tsukamoto M, Kakeya H, Yamamoto Y, Yanagihara K, Yasuoka A, Tashiro T, Kohno S.

Antimicrob Agents Chemother. 2012 Jan;56(1):584-7. doi: 10.1128/AAC.05394-11. Epub 2011 Oct 24.

50.

Evaluation of the Cica Fungi Test Candida, a novel serum Candida mannan antigen kit, and its comparison with Cand-Tec in candidemia patients.

Takazono T, Izumikawa K, Nagayoshi Y, Tanaka A, Mihara T, Kosai K, Saijo T, Imamura Y, Miyazaki T, Seki M, Kakeya H, Yamamoto Y, Yanagihara K, Kamihira S, Kohno S.

Jpn J Infect Dis. 2011;64(2):116-20.

Supplemental Content

Loading ...
Support Center